Category & trade
Primary
bone-and-joint-conditions · embed-ft 0.31
Tree path
Medical Health › Diseases and Conditions › Bone and Joint Conditions
Group (tier-1)
AI readiness
AI-Readiness score
18 / 100 · not-ready · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
RETAIN — Phase 2/3 trial of PLG0206 in PJI · Peptilogics
Description
RETAIN — a Phase 2/3 randomized, double-blind, placebo-controlled trial of PLG0206 as an adjunct to DAIR for periprosthetic joint infection following total knee arthroplasty. NCT07214311.
Final URL
Language
en (html)
Scanned at
2026-06-26 12:26:54